CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Market dynamics

3.2.1.Drivers

3.2.1.1.Increase in number of infertility cases globally
3.2.1.2.Alcohol consumption leading to infertility issues
3.2.1.3.Rise in awareness regarding infertility treatment options
3.2.1.4.Growth in prevalence of causative factors

3.2.2.Restraints

3.2.2.1.Impact of COVID-19 on the surrogacy market
3.2.2.2.Stringent regulations pertaining commercial surrogacy

3.2.3.Opportunity

3.2.3.1.Rise in fertility tourism

3.3.COVID-19 impact on the market

CHAPTER 4:SURROGACY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast, by type
4.1.2.Market size and forecast, by type

4.2.Gestational Surrogacy

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region

4.3.Traditional Surrogacy

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market size and forecast, by region

CHAPTER 5:SURROGACY MARKET, BY TECHNOLOGY

5.1.Overview

5.1.1.Market size and forecast (Value)
5.1.2.Market size and forecast (volume)

5.2.IVF with ICSI

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region

5.3.IVF without ICSI

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region

5.4.Intrauterine Insemination

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region

CHAPTER 6:SURROGACY MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast, by region

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by type
6.2.3.Market size and forecast, by technology

6.2.3.1.U.S. market size and forecast, by type
6.2.3.2.U.S. market size and forecast, by technology
6.2.3.3.Canada market size and forecast, by type
6.2.3.4.Canada market size and forecast, by technology
6.2.3.5.Mexico market size and forecast, by type
6.2.3.6.Mexico market size and forecast, by technology

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by type
6.3.3.Market size and forecast, by technology

6.3.3.1.UK market size and forecast, by type
6.3.3.2.UK market size and forecast, by technology
6.3.3.3.Rest of Europe market size and forecast, by type
6.3.3.4.Rest of Europe market size and forecast, by technology

6.4.Asia-pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by type
6.4.3.Market size and forecast, by technology

6.4.3.1.India market size and forecast, by type
6.4.3.2.India market size and forecast, by technology
6.4.3.3.Australia market size and forecast, by type
6.4.3.4.Australia market size and forecast, by technology
6.4.3.5.Rest of Asia-Pacific market size and forecast, by type
6.4.3.6.Rest of Asia-Pacific market size and forecast, by technology

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by type
6.5.3.Market size and forecast, by technology

6.5.3.1.Brazil market size and forecast, by type
6.5.3.2.Brazil market size and forecast, by technology
6.5.3.3.South Africa market size and forecast, by type
6.5.3.4.South Africa market size and forecast, by technology
6.5.3.5.Rest of LAMEA market size and forecast, by type
6.5.3.6.Rest of LAMEA market size and forecast, by technology

CHAPTER 7:COMPANY PROFILES

7.1.NEW HOPE FERTILITY CLINIC

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments

7.2.IVI RMA GLOBAL

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments

7.3.HOUSTON FERTILITY CENTER

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments

7.4.CLINIC SCANFERT

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments

7.5.BOURN HALL FERTILITY CLINIC

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments

7.6.NOVA IVI FERTILITY

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments

7.7.OVATION FERTILITY

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments

7.8.EXTRAORDINARY CONCEPTIONS

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments

7.9.CARE FERTILITY GROUP

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments

7.10.GROWING GENERATIONS LLC

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments